Extracellular Taurine in the Substantia Nigra: Taurine-Glutamate Interaction

Journal of Neuroscience Research

Volumn 76, Issue 4, 2004, Pages 528-538

  García Dopico, José ^a   Perdomo Díaz, Juan ^b   Alonso, Teofilo Jorge ^b   González Hernández, Tomás ^b   Castro Fuentes, Rafael ^b   Rodríguez Díaz, Manuel ^b,c  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

GABA; Glutamate; Parkinson's disease; Substantia nigra; Taurine; Zinc

Indexed keywords

4 AMINOBUTYRIC ACID; CALCIUM ION; GLUTAMATE RECEPTOR AGONIST; GLUTAMIC ACID; POTASSIUM ION; TAURINE; ZINC;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PARKINSON DISEASE; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ADRENERGIC AGENTS; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ASPARTIC ACID; BRAIN CHEMISTRY; CALCIUM; CHELATING AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EGTAZIC ACID; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; KAINIC ACID; KETAMINE; MALE; MEMBRANE POTENTIALS; MICRODIALYSIS; N-METHYLASPARTATE; OXIDOPAMINE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TAURINE; TIME FACTORS; ZINC;

EID: 2342534534     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20108     Document Type: Article

References (142)

1. Allen IC, Grieve A, Griffiths R. 1986. Differential changes in the content of amino acid neurotransmitters in discrete regions of the rat brain prior to the onset and during the course of homocysteine-induced seizures. J Neurochem 46:1582-1592.
2. Anderson KD, Reiner A. 1991. Striatonigral projection neurons: a retrograde labeling study of the percentages that contain substance P or enkephalin in pigeons. J Comp Neurol 303:658-673.
3. Aosaki T, Graybiel AM, Kimura M. 1994. Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. Science 265:412-415.
4. 2+ binding sites in the N-terminal domain of the prion protein by EPR and CD spectroscopy. Biochemistry 39:13760-13771.
5. 3H]kainate. Brain Res 658:209-218.
6. Barakat L, Wang D, Bordey A. 2002. Carrier-mediated uptake and release of taurine from Bergmann glia in rat cerebellar slices. J Physiol 541:753-767.
7. Beninato M, Spencer RF. 1987. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus. Brain Res 412:169-174.
8. Bianchi L, Colivicchi MA, Bolam JP, Della Corte L. 1998. The release of amino acids from rat neostriatum and substantia nigra in vivo: a dual microdialysis probe analysis. Neuroscience 87:171-180.
9. Bickford ME, Hall WC. 1992. The nigral projection to predorsal bundle cells in the superior colliculus of the rat. J Comp Neurol 319:11-33.
10. Biggs CS, Fowler LJ, Whitton PS, Starr MS. 1995. Impulse-dependent and tetrodotoxin-sensitive release of GABA in the rat's substantia nigra measured by microdialysis. Brain Res 684:172-178.
11. Bischoff S, Barhanin J, Bettler B, Mulle C, Heinemann S. 1997. Spatial distribution of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon. J Comp Neurol 379:541-562.
12. Bolam JP, Francis CM, Henderson Z. 1991. Cholinergic input to dopaminergic neurons in the substantia nigra: a double immunocytochemical study. Neuroscience 41:483-494.
13. Bonci A, Grillner P, Siniscalchi A, Mercuri NB, Bernardi G. 1997. Glutamate metabotropic receptor agonists depress excitatory and inhibitory transmission on rat mesencephalic principal neurons. Eur J Neurosci 9:2359-2369.
14. Butcher SP, Lazarewicz JW, Hamberger A. 1987. In vivo microdialysis studies on the effects of decortication and excitotoxic lesions on kainic acid-induced calcium fluxes, and endogenous amino acid release, in the rat striatum. J Neurochem 49:1355-1360.
15. Chatha BT, Bernard V, Streit P, Bolam JP. 2000. Synaptic localization of ionotropic glutamate receptors in the rat substantia nigra. Neuroscience 101:1037-1051.
16. Chergui K, Akaoka H, Charlety PJ, Saunier CF, Buda M, Chouvet G. 1994. Subthalamic nucleus modulates burst firing of nigral dopamine neurones via NMDA receptors. Neuroreport 5:1185-1188.
17. Chittajallu B, Vignes M, Dev KK, Barnes JM, Collingridge GL, Henley JM. 1996. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 379:78-81.
18. Christine CW, Choi DW. 1990. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J Neurosci 10:108-116.
19. Christoffersen CL, Meltzer LT. 1995. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutarnate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Neuroscience 67:373-381.
20. Clarke DD, Nicklas WJ, Berl S. 1970. Tricarboxylic acid-cycle metabolism in brain. Effect of fluoroacetate and fluorocitrate on the labelling of glutamate, aspartate, glutamine and gamma-aminobutyrate. Biochem J 120:345-351.
21. 3H]taurine into medium-size neurons and into identified striatonigral neurons in the rat neostriatum. Brain Res 289:342-348.
22. Clarke VR, Ballyk BA, Hoo KH, Mandelzys A, Pellizzari A, Bath CP, Thomas J, Sharpe EF, Davies CH, Ornstein PL, Schoepp DD, Kamboj RK, Collingridge GL, Lodge D, Bleakman D. 1997. A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389:599-603.
23. Colivicchi MA, Bianchi L, Bolam JP, Galeffi F, Frosini M, Palmi M, Sgaragli G, Della Corte L. 1998. The in vivo release of taurine in the striatonigral pathway. Adv Exp Med Biol 442:363-370.
24. Collingridge GL, Davies J. 1981. The influence of striatal stimulation and putative neurotransmitters on identified neurones in the rat substantia nigra. Brain Res 212:345-359.
25. Del Arco A, Segovia G, Fuxe K, Mora F. 2003. Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? J Neurochem 85:23-33.
26. Deleuze C, Duvoid A, Hussy N. 1998. Properties and glial origin of osmotic-dependent release of taurine from the rat supraoptic nucleus. J Physiol 507:463-471.
27. 3H]taurine uptake in the rat substantia nigra in relation to the release of taurine from the striatonigral pathway. Eur J Neurosci 2:50-61.
28. DeLong MR. 1990. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
29. Di Loreto S, Florio T, Scarnati E. 1992. Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons. Exp Brain Res 89:79-86.
30. Dray A, Gonye TJ, Oakley NR. 1976. Caudate stimulation and substantia nigra activity in the rat. J Physiol 259:825-849.
31. El Idrissi A, Trenkner E. 1999. Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19:9459-9468.
32. Faull RL, Mehler WR. 1978. The cells of origin of nigrotectal, nigrothalamic and nigrostriatal projections in the rat. Neuroscience 3:989-1002.
33. Flores-Hernandez J, Galarraga E, Bargas J. 1997. Dopamine selects glutamatergic inputs to neostriatal neurons. Synapse 25:185-195.
34. Fonnum F, Paulsen RE. 1990. Comparison of transmitter amino acid levels in rat globus pallidus and neostriatum during hypoglycemia or after treatment with methionine sulfoximine or gamma-vinyl gamma-aminobutyric acid. J Neurochem 54:1253-1257.
35. Frerking M, Nicoll RA. 2000. Synaptic kainate receptors. Curr Opin Neurobiol 10:342-351.
36. Gabrielsson B, Robson T, Norris D, Chung SH. 1986. Effects of divalent metal ions on the uptake of glutamate and GABA from synaptosomal fractions. Brain Res 384:218-223.
37. Gerfen CR, Baimbridge KG, Thibault J. 1987a. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J Neurosci 7:3935-3944.
38. Gerfen CR, Herkenham M, Thibault J. 1987b. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915-3934.
39. Gonzalez-Hernandez T, Rodriguez M. 2000. Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat. J Comp Neurol 421:107-135.
40. Gotz T, Kraushaar U, Geiger J, Lubke J, Berger T, Jonas P. 1997. Functional properties of AMPA and NMDA receptors expressed in identified types of basal ganglia neurons. J Neurosci 17:204-215.
41. Hanley JJ, Bolam JP. 1997. Synaptology of the nigrostriatal projection in relation to the compartmental organization of the neostriatum in the rat. Neuroscience 81:353-370.
42. Hantraye P, Brouillet E, Ferrante R, Palfi S, Dolan R, Matthews RT, Beal MF. 1996. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat Med 2:1017-1021.
43. Harata N, Katayama J, Takeshita Y, Murai Y, Akaike N. 1996. Two components of metabotropic glutamate responses in acutely dissociated CA3 pyramidal neurons of the rat. Brain Res 711:223-233.
44. Hassel B, Paulsen RE, Johnsen A, Fonnum F. 1992. Selective inhibition of glial cell metabolism in vivo by fluorocitrate. Brain Res 576:120-124.
45. - conductance in substantia nigra dopamine neurones. Brain Res 571:103-108.
46. Hedreen JC, DeLong MR. 1991. Organization of striatopallidal, striatonigral, and nigrostriatal projections in the macaque. J Comp Neurol 304: 569-595.
47. Hendil KB, Hoffmann EK. 1974. Cell volume regulation in Ehrlich ascites tumor cells. J Cell Physiol 84:115-125.
48. Herrera-Marschitz M, You ZB, Goiny M, Meana JJ, Silveira R, Godukhin OV, Chen Y, Espinoza S, Pettersson E, Loidl CF, Lubec G, Andersson K, Nylander I, Terenius L, Ungerstedt U. 1996. On the origin of extracellular glutamate levels monitored in the basal ganglia of the rat by in vivo microdialysis. J Neurochem 66:1726-1735.
49. Hori N, Galeno T, Carpenter DO. 1987. Responses of pyriform cortex neurons to excitatory amino acids: voltage dependence, conductance changes, and effects of divalent cations. Cell Mol Neurobiol 7:73-90.
50. Hubert GW, Paquet M, Smith Y. 2001. Differential subcellular localization of mGluR1a and mGluR5 in the rat and monkey substantia nigra. J Neurosci 21:1838-1847.
51. Huxtable RJ. 1992. Physiological actions of taurine. Physiol Rev 72:101-163.
52. Izumi K, Butterworth RF, Barbeau A. 1977. Effect of taurine on calcium binding to microsomes isolated from rat cerebral cortex. Life Sci 20:943-950.
53. Jacobson I, Hamberger A. 1985. Kainic acid-induced changes of extracellular amino acid levels, evoked potentials and EEG activity in the rabbit olfactory bulb. Brain Res 348:289-296.
54. James TA, Starr MS. 1979. Is glycine an inhibitory synaptic transmitter in the substantia nigra? Eur J Pharmacol 57:115-125.
55. Jenner P, Olanow CW. 1996. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47:S161-170.
56. Jenner P, Olanow CW. 1998. Understanding cell death in Parkinson's disease. Ann Neurol 44:S72-S84.
57. Kamiya H, Ozawa S. 2000. Kainate receptor-mediated presynaptic inhibition at the mouse hippocampal mossy fibre synapse. J Physiol 523:653-665.
58. Katayama J, Akaike N, Nabekura J. 2003. Characterization of pre- and post-synaptic metabotropic glutamate receptor-mediated inhibitory responses in substantia nigra dopamine neurons. Neurosci Res 45:101-115.
59. Katoh H, Sima K, Nawashiro H, Wada K, Chigasaki H. 1997. The effect of MK-801 on extracellular neuroactive amino acids in hippocampus after closed head injury followed by hypoxia in rats. Brain Res 758:153-162.
60. Kauppinen RA, Enkvist K, Holopainen I, Akerman KE. 1988. Glucose deprivation depolarizes plasma membrane of cultured astrocytes and collapses transmembrane potassium and glutamate gradients. Neuroscience 26:283-289.
61. Kitano H, Tanibuchi I, Jinnai K. 1998. The distribution of neurons in the substantia nigra pars reticulata with input from the motor, premotor and prefrontal areas of the cerebral cortex in monkeys. Brain Res 784:228-238.
62. Kontro P, Oja SS. 1987. Taurine and GABA release from mouse cerebral cortex slices: potassium stimulation releases more taurine than GABA from developing brain. Brain Res 465:277-291.
63. Kontro P, Oja SS. 1988. Release of taurine, GABA and dopamine from rat striatal slices: mutual interactions and developmental aspects. Neuroscience 24:49-58.
64. Laake JH, Slyngstad TA, Haug FM, Ottersen OP. 1995. Glutamine from glial cells is essential for the maintenance of the nerve terminal pool of glutamate: immunogold evidence from hippocampal slice cultures. J Neurochem 65:871-881.
65. Lehmann A, Isacsson H, Hamberger A. 1983. Effects of in vivo administration of kainic acid on the extracellular amino acid pool in the rabbit hippocampus. J Neurochem 40:1314-1320.
66. Lehmann A, Hagberg H, Hamberger A. 1984. A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation? Neurosci Lett 52:341-346.
67. Lehmann A, Lazarewicz JW, Zeise M. 1985a. N-methylaspartate-evoked liberation of taurine and phosphoethanolamine in vivo: site of release. J Neurochem 45:1172-1177.
68. Lehmann A, Hagberg H, Jacobson I, Hamberger A. 1985b. Effects of status epilepticus on extracellular amino acids in the hippocampus. Brain Res 359:147-151.
69. Lerma J. 1997. Kainate reveals its targets. Neuron 19:1155-1158.
70. Leviel V, Cheramy A, Nieoullon A, Glowinski J. 1979. Symmetric bilateral changes in dopamine release from the caudate nuclei of the cat induced by unilateral nigral application of glycine and GABA-related compounds. Brain Res 175:259-270.
71. Maggio R, Liminga U, Gale K. 1990. Selective stimulation of kainate but not quisqualate or NMDA receptors in substantia nigra evokes limbic motor seizures. Brain Res 528:223-230.
72. Magnusson KR, Koerner JF, Larson AA, Smullin DH, Skilling SR, Beitz AJ. 1991. NMDA-, kainate- and quisqualate-stimulated release of taurine from electrophysiologically monitored rat hippocampal slices. Brain Res 549:1-8.
73. Mailly P, Charpier S, Mahon S, Menetrey A, Thierry AM, Glowinski J, Deniau JM. 2001. Dendritic arborizations of the rat substantia nigra pars reticulata neurons: spatial organization and relation to the lamellar compartmentation of striato-nigral projections. J Neurosci 21:6874-6888.
74. Malcangio M, Bartolini A, Ghelardini C, Bennardini F, Malmberg-Aiello P, Franconi F, Giotti A. 1989. Effect of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia. Psychopharmacology 98:316-320.
75. Mangin JM, Guyon A, Eugene D, Paupardin-Tritsch D, Legendre P. 2002. Functional glycine receptor maturation in the absence of glycinergic input in dopaminergic neurones of the rat substantia nigra. J Physiol 542:685-697.
76. Martin DL, Madelian V, Seligmann B, Shain W. 1990. The role of osmotic pressure and membrane potential in K(+)-stimulated taurine release from cultured astrocytes and LRM55 cells. J Neurosci 10:571-577.
77. Martinez-Murillo R, Villalba RM, Rodrigo J. 1989a. Electron microscopic localization of cholinergic terminals in the rat substantia nigra: an immunocytochemical study. Neurosci Lett 96:121-126.
78. Martinez-Murillo R, Villalba R, Montero-Caballero MI, Rodrigo J. 1989b. Cholinergic somata and terminals in the rat substantia nigra: an immunocytochemical study with optical and electron microscopic techniques. J Comp Neurol 281:397-415.
79. Massieu L, Tapia R. 1997. Glutamate uptake impairment and neuronal damage in young and aged rats in vivo. J Neurochem 69:1151-1160.
80. Menendez N, Herreras O, Solis JM, Herranz AS, Martin del Rio R. 1989. Extracellular taurine increase in rat hippocampus evoked by specific glutamate receptor activation is related to the excitatory potency of glutamate agonists. Neurosci Lett 102:64-69.
81. Menendez N, Solis JM, Herreras O, Sanchez Herranz A, Martin del Rio R. 1990. Role of endogenous taurine on the glutamate analogue-induced neurotoxicity in the rat hippocampus in vivo. J Neurochem 55:714-717.
82. Mercuri NB, Calabresi P, Bernardi G. 1988. Potassium ions play a role in the glycine-induced inhibition of rat substantia nigra zona compacta neurones. Brain Res 462:199-203.
83. Mereu G, Costa E, Armstrong DM, Vicini S. 1991. Glutamate receptor subtypes mediate excitatory synaptic currents of dopamine neurons in midbrain slices. J Neurosci 11:1359-1366.
84. Namima M, Okamoto K, Sakai Y. 1983. Modulatory action of taurine on the release of GABA in cerebellar slices of the guinea pig. J Neurochem 40:1-9.
85. Nicoll RA, Mellor J, Frerking M, Schmitz D. 2000. Kainate receptors and synaptic plasticity. Nature 406:957.
86. Nisenbaum ES, Grace AA, Berger TW. 1992. Functionally distinct subpopulations of striatal neurons are differentially regulated by GABAergic and dopaminergic inputs-II. In vitro analysis. Neuroscience 48:579-593.
87. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, Olanow CW. 2000. Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23:S8-S19.
88. Obrenovitch TP, Urenjak J. 1997. Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog Neurobiol 51:39-87.
89. Obrenovitch TP, Urenjak J, Zilkha E. 1994. Intracerebral microdialysis combined with recording of extracellular field potential: a novel method for investigation of depolarizing drugs in vivo. Br J Pharmacol 113:1295-1302.
90. Olanow CW, Tatton WG. 1999. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22:123-144.
91. Palkovits M, Elekes I, Lang T, Patthy A. 1986. Taurine levels in discrete brain nuclei of rats. J Neurochem 47:1333-1335.
92. Parent A, Hazrati LN. 1993. Anatomical aspects of information processing in primate basal ganglia. Trends Neurosci 16:111-116.
93. Parent A, Hazrati LN. 1994. Multiple striatal representation in primate substantia nigra. J Comp Neurol 344:305-320.
94. Parent A, Hazrati LN. 1995a. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 20:91-127.
95. Parent A, Hazrati LN. 1995b. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128-154.
96. Pasantes-Morales H, Cruz C. 1984. Protective effect of taurine and zinc on peroxidation-induced damage in photoreceptor outer segments. J Neurosci Res 11:303-311.
97. Paternain AV, Rodriguez-Moreno A, Villarroel A, Lerma J. 1998. Activation and desensitization properties of native and recombinant kainate receptors. Neuropharmacology 37:1249-1259.
98. +-evoked release of transmitter amino acids investigated by microdialysis. J Neurochem 52:1823-1829.
99. Petegnief V, Lleu PL, Gupta RC, Bourguignon JJ, Rebel G. 1995. Taurine analog modulation of taurine uptake by two different mechanisms in cultured glial cells. Biochem Pharmacol 49:399-410.
100. Peters S, Koh J, Choi DW. 1987. Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons. Science 236:589-593.
101. Piallat B, Benazzouz A, Benabid AL. 1996. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur J Neurosci 8:1408-1414.
102. Pycock CJ. 1980. Turning behaviour in animals. Neuroscience 5:461-514.
103. Rampon C, Luppi PH, Fort P, Peyron C, Jouvet M. 1996. Distribution of glycine-immunoreactive cell bodies and fibers in the rat brain. Neuroscience 75:737-755.
104. Rassendren FA, Lory P, Pin JP, Nargeot J. 1990. Zinc has opposite effects on NMDA and non-NMDA receptors expressed in Xenopus oocytes. Neuron 4:733-740.
105. Redgrave P, Marrow L, Dean P. 1992. Topographical organization of the nigrotectal projection in rat: evidence for segregated channels. Neuroscience 50:571-595.
106. Rodriguez M, Barroso-Chinea P, Abdala P, Obeso J, Gonzalez-Hernandez T. 2001. Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease. Exp Neurol 169:163-181.
107. Rodriguez MC, Obeso JA, Olanow CW. 1998. Subthalamic nucleusmediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann Neurol 44:S175-S188.
108. Rodriguez-Moreno A, Herreras O, Lerma J. 1997. Kainate receptors presynaptically downregulate GABAergic inhibition in the rat hippocampus. Neuron 19:893-901.
109. Rodriguez-Moreno A, Lopez-Garcia JC, Lerma J. 2000. Two populations of kainate receptors with separate signaling mechanisms in hippocampal interneurons. Proc Natl Acad Sci USA 97:1293-1298.
110. Rothstein JD, Tabakoff B. 1984. Alteration of striatal glutamate release after glutamine synthetase inhibition. J Neurochem 43:1438-1446.
111. Rozza A, Masoero E, Favalli L, Lanza E, Govoni S, Rizzo V, Montalbetti L. 2000. Influence of different anaesthetics on extracellular aminoacids in rat brain. J Neurosci Methods 101:165-169.
112. Saransaari P, Oja SS. 1997a. Taurine release from the developing and ageing hippocampus: stimulation by agonists of ionotropic glutamate receptors. Mech Ageing Dev 99:219-232.
113. Saransaari P, Oja SS. 1997b. Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus. Neuroscience 79:847-854.
114. Saransaari P, Oja SS. 2003. Characterization of N-methyl-D-aspartate-evoked taurine release in the developing and adult mouse hippocampus. Amino Acids 24:213-221.
115. Sato K, ZhangJH, Saika T, Sato M, Tada K, Tohyama M. 1991. Localization of glycine receptor alpha 1 subunit mRNA-containing neurons in the rat brain: an analysis using in situ hybridization histochemistry. Neuroscience 43:381-395.
116. Schoepp DD, Jane DE, Monn JA. 1999. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38: 1431-1476.
117. Schurr A, Rigor BM. 1987. The mechanism of neuronal resistance and adaptation to hypoxia. FEBS Lett 224:4-8.
118. Schurr A, Tseng MT, West CA, Rigor BM. 1987. Taurine improves the recovery of neuronal function following cerebral hypoxia: an in vitro study. Life Sci 40:2059-2066.
119. Segovia G, Del Arco A, Mora F. 1997. Endogenous glutamate increases extracellular concentrations of dopamine, GABA, and taurine through NMDA and AMPA/kainate receptors in striatum of the freely moving rat: a microdialysis study. J Neurochem 69:1476-1483.
120. Sergeeva OA, Chepkova AN, Haas HL. 2002. Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum. Br J Pharmacol 137:855-860.
121. Smart TG, Xie X, Krishek BJ. 1994. Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc. Prog Neurobiol 42:393-341.
122. Smith AD, Bolam JP. 1990. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 13:259-265.
123. Smith ID, Grace AA. 1992. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12:287-303.
124. Soltis RP, Anderson LA, Walters JR, Kelland MD. 1994. A role for non-NMDA excitatory amino acid receptors in regulating the basal activity of rat globus pallidus neurons and their activation by the subthalamic nucleus. Brain Res 666:21-30.
125. Spiridon M, Kamm D, Billups B, Mobbs P, Attwell D. 1998. Modulation by zinc of the glutamate transporters in glial cells and cones isolated from the tiger salamander retina. J Physiol 506:363-376.
126. Szerb JC, Issekutz B. 1987. Increase in the stimulation-induced overflow of glutamate by fluoroacetate, a selective inhibitor of the glial tricarboxylic cycle. Brain Res 410:116-120.
127. Thomas EL, Grisham MB, Melton DF, Jefferson MM. 1985. Evidence for a role of taurine in the in vitro oxidative toxicity of neutrophils toward erythrocytes. J Biol Chem 260:3321-3329.
128. Timmerman W, Westerink BH. 1997. Brain microdialysis of GABA and glutamate: what does it signify? Synapse 27:242-261.
129. Tong ZY, Overton PG, Clark D. 1996a. Antagonism of NMDA receptors but not AMPA/kainate receptors blocks bursting in dopaminergic neurons induced by electrical stimulation of the prefrontal cortex. J Neural Transm 103:889-904.
130. Tong ZY, Overton PG, Clark D. 1996b. Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural burst events. Synapse 22:195-208.
131. Trenkner E. 1990. Possible role of glutamate with taurine in neuron-glia interaction during cerebellar development. Prog Clin Biol Res 351:133-140.
132. van Gelder NM. 1983. A central mechanism of action for taurine: osmoregulation, bivalent cations, and excitation threshold. Neurochem Res 8:687-699.
133. Vivo M, Camon L, de Vera N, Martinez E. 2002. Lesion of substantia nigra pars compacta by the GluR5 agonist ATPA. Brain Res 955:104-114.
134. Wade JV, Olson JP, Samson FE, Nelson SR, Pazdemik TL. 1988. A possible role for taurine in osmoregulation within the brain. J Neurochem 51:740-745.
135. 2+ antagonize NMDA and GABA responses of hippocampal neurons. Nature 328:640-643.
136. Westerink BH, Hofiteede HM, Damsma G, de Vries JB. 1988. The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn Schmiedebergs Arch Pharmacol 337:373-378.
137. Wigmore MA, Lacey MG. 1998. Metabotropic glutamate receptors depress glutamate-mediated synaptic input to rat midbrain dopamine neurones in vitro. Br J Pharmacol 123:667-674.
138. Wittmann M, Marino MJ, Bradley SR, Conn PJ. 2001. Activation of group III mGluRs inhibits GABAergic and glutamatergic transmission in the substantia nigra pars reticulata. J Neurophysiol 85:1960-1968.
139. Wright CE, Tallan HH, Lin YY, Gaull GE. 1986. Taurine: biological update. Annu Rev Biochem 55:427-453.
140. Wullner U, Standaert DG, Testa CM, Penney JB, Young AB. 1997. Differential expression of kainate receptors in the basal ganglia of the developing and adult rat brain. Brain Res 768:215-223.
141. Yamada K, Senzaki K, Komori Y, Nikai T, Sugihara H, Nabeshima T. 1997. Changes in extracellular nitrite and nitrate levels after inhibition of glial metabolism with fluorocitrate. Brain Res 762:72-78.
142. Ye G, Tse AC, Yung W. 1997. Taurine inhibits rat substantia nigra pars reticulata neurons by activation of GABA- and glycine-linked chloride conductance. Brain Res 749:175-179.